Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
GR 01 - What to Do at the Time of Progression on Targeted Therapy
- 11:00 - 12:30
- 10/16/2017
- Location: Room 303 + 304
- Type: Grand Rounds
- Track: Chemotherapy/Targeted Therapy
- Moderators:D. Kim, Lecia V Sequist
-
+
GR 01.01 - Case Study
11:00 - 11:05 | Presenter: D. Kim
- Abstract
No abstract available for this presentation
-
+
GR 01.02 - Case Study
11:05 - 11:10 | Presenter: Lecia V Sequist
- Abstract
No abstract available for this presentation
-
+
GR 01.03 - First-Line Management of EGFR Mutant NSCLC
11:10 - 11:30 | Presenter: Li Zhang
- Abstract
Loading... -
+
GR 01.04 - EGFR-Positive NSCLC Cases Who Failed Previous EGFR-TKI
11:30 - 11:50 | Presenter: Gregory J Riely
- Abstract
No abstract available for this presentation
-
+
GR 01.05 - First-Line Management of ALK Mutant NSCLC
11:50 - 12:10 | Presenter: Silvia Novello | Author(s): C. Mecca
- Abstract
Loading... -
+
GR 01.06 - ALK-Positive NSCLC Cases who Failed Previous ALK Inhibitors
12:10 - 12:30 | Presenter: Jürgen Wolf
- Abstract
No abstract available for this presentation
-
+
MA 01 - SCLC: Research Perspectives
- 11:00 - 12:30
- 10/16/2017
- Location: Room 503
- Type: Mini Oral
- Track: SCLC/Neuroendocrine Tumors
- Moderators:John V Heymach, Eun Kyung Cho
-
+
MA 01.01 - Metastatic Behavior of Pulmonary Neuroendocrine Carcinomas Is Associated with Epithelial to Mesenchymal Transition Gene Profile
11:00 - 11:05 | Presenter: Tabatha Gutierrez Prieto | Author(s): Vanessa Karen De Sá, E.H.R. Olivieri, E.C.A. Da Silva, R.M. Reis, D.M. Carraro, Vera Luiza Capelozzi
- Abstract
Loading... -
+
MA 01.02 - Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers Versus Heavy Smokers
11:05 - 11:10 | Presenter: Andrés F. Cardona | Author(s): Oscar Arrieta, L. Rojas, Z.L. Zatarain-Barron, L. Corrales, Claudio Martin, J. Rodriguez, J. Rodriguez, P. Archila, Alejandro Ruiz-Patiño, Rafael Rosell
- Abstract
Loading... -
+
MA 01.03 - The Potential of ctDNA Sequencing in Disease Monitoring and Depicting Genomic Evolution of Small-Cell Lung Cancer Under Therapy
11:10 - 11:15 | Presenter: Vincent K Lam | Author(s): J. Wang, Y. Gong, J. Nong, Y. Yi, Y. Guan, L. Yang, H. Jia, S. Zhang, X. Yi, Z. Liao, Vassiliki A Papadimitrakopoulou, Ignacio I. Wistuba, John V Heymach, B. Glisson, A. Futreal, X. Xia, Jianjun Zhang
- Abstract
Loading... -
+
MA 01.04 - Discussant - MA 01.01, MA 01.02, MA 01.03
11:15 - 11:30 | Presenter: Charles Andrew Butts
- Abstract
No abstract available for this presentation
-
+
MA 01.05 - Activity and Safety of the Combination of PM01183 and Doxorubicin in Relapsed SCLC. Final Results of a Phase Ib Trial
11:30 - 11:35 | Presenter: Emiliano Calvo | Author(s): M. Forster, V. Moreno, M.E. Olmedo, M.P. Lopez Criado, Jose Antonio Lopez-Vilariño, C. Kahatt, A. Soto-Matos
- Abstract
Loading... -
+
MA 01.06 - A Phase II Study of Etirinotecan Pegol (NKTR-102) in Patients with Chemotherapy-Resistant Small Cell Lung Cancer
11:35 - 11:40 | Presenter: Hongbin Chen | Author(s): Grace K Dy, A. Groman, E. Farrell, A. Miller, P. Bushunow, Alex Adjei
- Abstract
Loading... -
+
MA 01.07 - Lanreotide Maintenance in SCLC Expressing Somatostatine Receptors: Efficacy Results of Multicenter Randomized G04.2011 Trial
11:40 - 11:45 | Presenter: Sara Pilotto | Author(s): E. Bria, Domenico Galetta, Francesco Grossi, G. Fasola, G. Romano, L. Bonanno, A. Bearz, M. Papi, A. Caprioli, A. Catino, A. Follador, E. Rijavec, A. Misino, G. Surico, A. Favaretto, L. Giannone, G. Tortora, D. Giannarelli, A. Santo
- Abstract
Loading... -
+
MA 01.08 - Discussant - MA 01.05, MA 01.06, MA 01.07
11:45 - 12:00 | Presenter: Anne Tsao
- Abstract
No abstract available for this presentation
-
+
MA 01.09 - Treatment Patterns in Extensive Disease Small Cell Lung Cancer Across the United States, Europe, and Japan
12:00 - 12:05 | Presenter: Yong Yuan | Author(s): K. Higginbottom, M. Dibonaventura, J.R. Penrod
- Abstract
Loading... -
+
MA 01.10 - Outcome Based on Baseline Total Lymphocyte Count & Neutrophil-To-Lymphocyte Ratio in Extensive Stage Small-Cell Lung Cancer
12:05 - 12:10 | Presenter: Ryoko Suzuki | Author(s): S.H. Lin, X. Wei, P.K. Allen, J.W. Welsh, L.A. Byers, Ritsuko Komaki
- Abstract
Loading... -
+
- Abstract
Loading... -
+
MA 01.12 - Discussant - MA 01.09, MA 01.10, MA 01.11
12:15 - 12:30 | Presenter: Anand Swaminath
- Abstract
No abstract available for this presentation
-
+
MA 02 - Emerging Targets
- 11:00 - 12:30
- 10/16/2017
- Location: Room 511 + 512
- Type: Mini Oral
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:Ravi Salgia, Shun Lu
-
+
MA 02.01 - Evidence of Clinical Activity of Sitravatinib in Combination with Nivolumab in NSCLC Patients Progressing on Prior Checkpoint Inhibitors
11:00 - 11:05 | Presenter: Ticiana A. Leal | Author(s): T. Campbell, A. Mapes, K. Schneider, M.J. Staab, K. Velastegui, J.G. Christensen, I. Chen, A. Traynor
- Abstract
Loading... -
+
MA 02.02 - Phase 2 Study of Pembrolizumab Plus CC-486 vs Pembrolizumab Plus Placebo in Previously Treated Patients with Advanced NSCLC
11:05 - 11:10 | Presenter: Luis Paz-Ares | Author(s): B.P. Levy, Giuseppe Giaccone, Benjamin Besse, Enriqueta Felip, Marina Chiara Garassino, M. Domine, Pilar Garrido, B. Piperdi, S. Ponce Aix, R. Slepetis, X. Wu, A. Fandi
- Abstract
Loading... -
+
MA 02.03 - Selective Histone Deacetylase Inhibitor ACY-241 Plus Nivolumab for Refractory Advanced NSCLC: Results From a Phase 1b Study
11:10 - 11:15 | Presenter: Mark Awad | Author(s): Y. Le Bruchec, R. Markelewicz, P. Chen, A. Fandi, A. Spira
- Abstract
Loading... -
+
MA 02.04 - Discussant - MA 02.01, MA 02.02, MA 02.03
11:15 - 11:30 | Presenter: Grace K Dy
- Abstract
No abstract available for this presentation
-
+
MA 02.05 - Nivolumab in Advanced Non-Squamous NSCLC Patients with KRAS Mutations: Results from the Italian Expanded Access Program (EAP)
11:30 - 11:35 | Presenter: Domenico Galetta | Author(s): A. Ardizzoni, P. Bidoli, R. Chiari, L. Bonomi, D. Turci, L. Landi, L. Toschi, M. De Tursi, G. Francini, M. Giordano, O. Alabiso, A. De Censi, L. Livi, A. Berruti, M. Minelli, E. Ricevuto, A. Illiano, G. Puppo, A. Delmonte
- Abstract
Loading... -
+
MA 02.06 - BRAF Mutant NSCLC: Correlation with PD-L1 Expression,TMB, MSI and Response to ICPi and Anti-BRAF Therapy
11:35 - 11:40 | Presenter: Elizabeth Dudnik | Author(s): Nir Peled, M. Wollner, Amir Onn, A. Agbareya, H. Nechushtan, T. Kuznetsov, L.C. Roisman, A. Belilovski Rozenblum, Smadar Geva, A. Zer, Jair Bar
- Abstract
Loading... -
+
MA 02.07 - A Phase II Study of Pembrolizumab in EGFR Mutant, PD-L1+, Tyrosine Kinase Inhibitor (TKI) Naïve Patients with Advanced NSCLC
11:40 - 11:45 | Presenter: Aaron Lisberg | Author(s): J. Hunt, N. Reese, T. Wang, P. Coluzzi, M. Spiegel, K. Bornazyan, J. Carroll, J. Madrigal, B. Ledezma, M. Mendenhall, J.L. Bui, H. Lu, A. Cummings, Z. Noor, Jonathan W. Goldman, Edward Brian Garon
- Abstract
Loading... -
+
MA 02.08 - Discussant - MA 02.05, MA 02.06, MA 02.07
11:45 - 12:00 | Presenter: Barbara Melosky
- Abstract
No abstract available for this presentation
-
+
MA 02.09 - A Ph I/II Study of BGB324, a Selective AXL Inhibitor as Monotherapy and in Combination with Erlotinib in Advanced NSCLC
12:00 - 12:05 | Presenter: Don Lynn Gibbons | Author(s): L. Byers, David E Gerber, J. Peguero, D. Micklem, M. Yule, J. Lorens
- Abstract
Loading... -
+
MA 02.10 - Phase I Study of ABBV-399 (Telisotuzumab Vedotin) as Monotherapy and in Combination with Erlotinib in NSCLC
12:05 - 12:10 | Presenter: Jonathan Wade Goldman | Author(s): E. Angevin, J. Strickler, D. Ross Camidge, R. Heist, D. Morgensztern, M. Barve, H. Yue, J. Beaulieu, M. Motwani, D. Afar, L. Naumovski, Karen Kelly
- Abstract
Loading... -
+
MA 02.11 - A Phase I Trial of Erlotinib and Onalespib in EGFR-mutant NSCLC: Focus on EGFR Exon 20 Insertions
12:10 - 12:15 | Presenter: Jonathan W Riess | Author(s): Karen L Reckamp, J. Longmate, Karen Kelly, David R. Gandara, Philip Christopher Mack, E. Newman, Primo Lara
- Abstract
Loading... -
+
MA 02.12 - Discussant - MA 02.09, MA 02.10, MA 02.11
12:15 - 12:30 | Presenter: Dean A Fennell
- Abstract
No abstract available for this presentation
-
+
MA 03 - Chemotherapy
- 11:00 - 12:30
- 10/16/2017
- Location: Room 502
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Jin-Hyoung Kang, W. Su
-
+
MA 03.01 - Nab-Paclitaxel ± CC-486 as Second-Line Treatment of Advanced NSCLC: Results from the ABOUND.2L+ Study
11:00 - 11:05 | Presenter: Ramaswamy Govindan | Author(s): D. Morgensztern, Manuel Cobo Dols, S. Ponce Aix, Pieter E. Postmus, Jaafar Bennouna, J.R. Fischer, O.J. Vidal, D.J. Stewart, G. Fasola, J. Weaver, M. Wolfsteiner, T.J. Ong
- Abstract
Loading... -
+
MA 03.02 - Timing of B12/Folate Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy: Final Results of the PEMVITASTART Randomized Trial
11:05 - 11:10 | Presenter: Navneet Singh | Author(s): M. Baldi, J. Kaur, Kuruswamy Thurai Prasad, R. Kapoor, Digambar Behera
- Abstract
Loading... -
+
MA 03.03 - Nedaplatin plus Docetaxel versus Cisplatin plus Docetaxel as First-Line Chemotherapy for Advanced Squamous Cell Carcinoma of the Lung
11:10 - 11:15 | Presenter: Shun Lu | Author(s): Z. Chen, C.P. Hu, R. Xin-Ling, Y. Chen, Yong Song, Z. Qiong, Yun Fan, W. Gang, M. Zhi-Yong, Jian Fang, Y. Qi-Tao, Z. Liu
- Abstract
Loading... -
+
MA 03.04 - Discussant - MA 03.01, MA 03.02, MA 03.03
11:15 - 11:30 | Presenter: Adrian G. Sacher
- Abstract
No abstract available for this presentation
-
+
MA 03.05 - Bevacizumab Combined with Chemotherapy for Patients with Advanced NSCLC and Brain Metastasis. A French Cohort Study
11:30 - 11:35 | Presenter: Jaafar Bennouna | Author(s): L. Falchero, R. Schott, F. Bonnetain, M. Coudert, B. Ben Hadj Yahia, C. Chouaid
- Abstract
Loading... -
+
MA 03.06 - Effect of 2L Ramucirumab after Rapid Time to Progression on 1L Therapy: Subgroup Analysis of REVEL in Advanced NSCLC
11:35 - 11:40 | Presenter: Martin Reck | Author(s): Frances A Shepherd, Maurice Pérol, Frederico Cappuzzo, J. Shih, Keunchil Park, K.B. Winfree, E. Alexandris, P. Lee, A. Sashegyi, Edward Brian Garon
- Abstract
Loading... -
+
- Abstract
Loading... -
+
MA 03.08 - Discussant - MA 03.05, MA 03.06, MA 03.07
11:45 - 12:00 | Presenter: Ikuo Sekine
- Abstract
No abstract available for this presentation
-
+
MA 03.09 - The Cost and the Benefit: Front-Line Immunotherapy for Non-Small Cell Lung Cancer
12:00 - 12:05 | Presenter: Christine M Bestvina | Author(s): Everett E Vokes, P.C. Hoffman, J. Patel
- Abstract
Loading... -
+
MA 03.10 - Prognostic Factors in NSCLC Patients Treated with a Fourth-Line Therapy
12:05 - 12:10 | Presenter: Vincent Leroy | Author(s): J. Labreuche, T. Gey, G. Terce, M.C. Willemin, X. Dhalluin, E. Wasielewski, A. Scherpereel, Alexis B Cortot
- Abstract
Loading... -
+
MA 03.11 - Targeting CDCA3 Enhances Sensitivity to Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer
12:10 - 12:15 | Presenter: Mark N Adams | Author(s): J. Burgess, D. Richard, Kenneth Obyrne
- Abstract
Loading... -
+
MA 03.12 - Discussant - MA 03.09, MA 03.10, MA 03.11
12:15 - 12:30 | Presenter: Mary Obrien
- Abstract
No abstract available for this presentation
-
+
MA 04 - Advocacy: Listen to the Patients
- 11:00 - 12:30
- 10/16/2017
- Location: Room 313 + 314
- Type: Mini Oral
- Track: Patient Advocacy
- Moderators:Rudolf M Huber, C.L. Dégi
-
+
MA 04.01 - Prospective Comparative Evaluation of Patient and Caregiver Perspectives on a Multidisciplinary Model of Lung Cancer Care
11:00 - 11:05 | Presenter: Matthew P Smeltzer | Author(s): K.D. Ward, F.E. Rugless, N.R. Faris, M.A. Ray, B. Jackson, C. Foust, A. Patel, M. Meadows, N. Boateng, K. Roark, F. Crossley, G. Oliver, L. McHugh, W. Hastings, O. Osborne, J. Osborne, T. Ill, M. Ill, R.S. Signore, R. Fox, E.T. Robbins, Raymond U. Osarogiagbon
- Abstract
Loading... -
+
MA 04.02 - Assessing the Psychosocial Needs of Newly Diagnosed NSCLC Patients: Identifying the Population Most At-Risk
11:05 - 11:10 | Presenter: Bonnie Leung | Author(s): H. Naik, J. Laskin, J. Wu, R. Mackenzie, A. Bates, C. Ho
- Abstract
Loading... -
+
MA 04.04 - Discussant - MA 04.01, MA 04.02, MA 04.03
11:10 - 11:25 | Presenter: Kathy Weber
- Abstract
No abstract available for this presentation
-
+
MA 04.05 - The Impact of the Meso Foundation on Advocacy Efforts for Funding Mesothelioma Research
11:25 - 11:30 | Presenter: M. Kotizan | Author(s): Gleneara Elizabeth Bates, J. Mostel, Mary Hesdorffer
- Abstract
Loading... -
+
MA 04.06 - Developing a Lung Cancer Clinical Quality Registry Framework to Collect Longitudinal Patient-Reported Outcomes
11:30 - 11:35 | Presenter: Mary Duffy | Author(s): N. Moloczij, K. Gough, David L Ball, Ben J Solomon, L. Mileshkin, M. Krishnasamy
- Abstract
Loading... -
+
MA 04.07 - Understanding Patient Barriers to Utilization of Low Dose CT Lung Cancer Screening
11:35 - 11:40 | Presenter: Cherie Parungo Erkmen | Author(s): F. Dako
- Abstract
Loading... -
+
MA 04.08 - Discussant - MA 04.05, MA 04.06, MA 04.07
11:40 - 11:55 | Presenter: Andrea Katalin Borondy Kitts
- Abstract
No abstract available for this presentation
-
+
MA 04.09 - A Study on the Damage of Passive Smoking to Japanese Lung Cancer Patients
11:55 - 12:00 | Presenter: Kazuo Hasegawa | Author(s): T. Yamaoka, Satoko Kono, H. Nakahara
- Abstract
Loading... -
+
MA 04.10 - An Assessment of the Willingness to Provide Serial Bio-Specimens: Experience from an Irish Tertiary Cancer Centre
12:00 - 12:05 | Presenter: Anne-Marie Baird | Author(s): N.M. Keegan, Martin P Barr, S. Fishleder, A.F. Idris, E. Harrold, P. O'Kelly, E. Duff, S. Lim, M. O'Donnell, D.J. Gallagher, C. Grant, J. Kennedy, D.M. O'Donnell, S. Sukor, C.P. O'Brien, Stephen P Finn, S. Cuffe
- Abstract
Loading... -
+
MA 04.11 - A Comprehensive Vision to Reduce Lung Cancer Stigma: Changing Cultural Perspectives on Lung Cancer
12:05 - 12:10 | Presenter: Angela Meredith Criswell | Author(s): Maureen Rigney, J.L. Studts
- Abstract
Loading... -
+
MA 04.12 - Discussant - MA 04.09, MA 04.10, MA 04.11
12:10 - 12:25 | Presenter: Sita Andarini
- Abstract
No abstract available for this presentation
-
+
MA 04.13 - Q&A
12:25 - 12:30
- Abstract
No abstract available for this presentation
-
+
MS 01 - Clinical Development of Novel Agents
- 11:00 - 12:30
- 10/16/2017
- Location: Main Hall
- Type: Mini Symposium
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:S. Mandrekar, M. Mori
-
+
MS 01.01 - Expansion Cohorts in Phase I Trials: Non Controlled Phase II or Translational Science?
11:00 - 11:20 | Presenter: Benjamin Besse
- Abstract
No abstract available for this presentation
-
+
MS 01.02 - Are We Categorizing Biomarkers Too Quickly?
11:20 - 11:40 | Presenter: Jack Lee
- Abstract
No abstract available for this presentation
-
+
MS 01.03 - Innovative Trial Designs: What is the Minimal Burden of Proof for Drug Approval?
11:40 - 12:00 | Presenter: Giuseppe Giaccone
- Abstract
No abstract available for this presentation
-
+
MS 01.04 - Is "Big Data" the Solution to the Complex Therapeutic Landscape?
12:00 - 12:20 | Presenter: Yu Shyr
- Abstract
Loading... -
+
MS 01.05 - Q&A
12:20 - 12:30
- Abstract
No abstract available for this presentation
-
+
MS 02 - Ethnic Differences: Biology or Myth
- 11:00 - 12:30
- 10/16/2017
- Location: Room 501
- Type: Mini Symposium
- Track: Regional Aspects/Health Policy/Public Health
-
+
MS 02.01 - Lung Cancer Genomics
11:30 - 11:45 | Presenter: Ramaswamy Govindan
- Abstract
Loading... -
+
MS 02.02 - Molecular Epidemiology
11:15 - 11:30 | Presenter: Tomoya Kawaguchi | Author(s): K. Sawa, N. Yoshimoto, K. Hirata, Philip Christopher Mack
- Abstract
Loading... -
+
MS 02.03 - Chemotherapy: Efficacy and Toxicity Difference According to Ethnicity
11:00 - 11:15 | Presenter: Martin Edelman
- Abstract
Loading... -
+
MS 02.04 - Targeted Agents and Immunotherapy: Efficacy and Toxicity Difference According to Ethnicity
11:45 - 12:00 | Presenter: Luis Paz-Ares
- Abstract
No abstract available for this presentation
-
+
MS 02.05 - Is Ethnicity a Prognostic Factor in Lung Cancer
12:00 - 12:15 | Presenter: Viola Zhu
- Abstract
Loading... -
+
MS 02.06 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
MS 03 - Best Practice for Small-Sized Early Stage Lung Cancer: Standard Surgery, Limited Resection, SBRT
- 11:00 - 12:30
- 10/16/2017
- Location: F203 + F204 (Annex Hall)
- Type: Mini Symposium
- Track: Early Stage NSCLC
- Moderators:H.Y. Lee, Masami Sato
-
+
MS 03.01 - Limited vs. Standard Surgical Resection: North American Experience
11:00 - 11:15 | Presenter: Nasser Altorki
- Abstract
No abstract available for this presentation
-
+
MS 03.02 - Limited vs. Standard Surgical Resection: Japanese Experience
11:15 - 11:30 | Presenter: Hisao Asamura
- Abstract
Loading... -
+
MS 03.03 - Limited vs. Standard Surgical Resection: European Experience
11:30 - 11:45 | Presenter: Paul Emile Van Schil
- Abstract
Loading... -
+
MS 03.04 - Technical Aspects of Limited Resection
11:45 - 12:00 | Presenter: Harvey I Pass
- Abstract
Loading... -
+
MS 03.05 - SBRT Experience
12:00 - 12:15 | Presenter: Joe Y Chang
- Abstract
Loading... -
+
MS 03.06 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
MS 04 - Joint IASLC/GLCC Session Current Issues in Lung Cancer Advocacy
- 11:00 - 12:30
- 10/16/2017
- Location: Room 316
- Type: Mini Symposium
- Track: Patient Advocacy
- Moderators:Natasha B Leighl, Maureen Rigney
-
+
MS 04.01 - Lung Cancer Advocacy Tools for Everyone - The Use of GLCC Data
11:00 - 11:15 | Presenter: Jesme Fox
- Abstract
Loading... -
+
MS 04.02 - Lung Cancer Advocates and Measuring Value in Healthcare
11:15 - 11:30 | Presenter: Carolyn Aldige
- Abstract
Loading... -
+
MS 04.03 - Accessing New Lung Cancer Therapies - Challenges & Experience in Latin America
11:30 - 11:45 | Presenter: Mirna Patricia Mondragon
- Abstract
Loading... -
+
MS 04.04 - Patient Advocacy - Making a Difference for Lung Cancer Patients in Japan
11:45 - 12:00 | Presenter: Toshiyuki Sawa
- Abstract
Loading... -
+
MS 04.05 - Lung Cancer Patients and Stopping Smoking - What Advocates Need to Know
12:00 - 12:15 | Presenter: Aoife McNamara
- Abstract
Loading... -
+
MS 04.06 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
OA 01 - The New Aspect of Radiation Therapy
- 11:00 - 12:30
- 10/16/2017
- Location: F201 + F202 (Annex Hall)
- Type: Oral
- Track: Radiotherapy
- Moderators:M. Hiraoka, S.H. Kim
-
+
OA 01.01 - A Randomized Trial of SABR vs Conventional Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: TROG 09.02 (CHISEL)
11:00 - 11:10 | Presenter: David L Ball | Author(s): T. Mai, S.K. Vinod, S. Babington, J.D. Ruben, T. Kron, B. Chesson, A. Herschtal, A. Rezo, C. Elder, M. Skala, A. Wirth, G. Wheeler, A. Lim, M. Vanevski, M. Shaw
- Abstract
Loading... -
+
OA 01.02 - Stereotactic Radiotherapy as Salvage Treatment After Surgery and Curative Intended Radiotherapy for Patients with NSCLC
11:10 - 11:20 | Presenter: Olfred Hansen | Author(s): C. Kristiansen, Stefan Starup Jeppesen, T.B. Nielsen, T. Schytte, M. Nielsen
- Abstract
Loading... -
+
OA 01.03 - Patterns of Change in High-Risk Radiological Features in Patients without Local Recurrence after SABR for Early-Stage NSCLC
11:20 - 11:30 | Presenter: Merle Ilona Ronden
- Abstract
Loading... -
+
OA 01.04 - Discussant - OA 01.01, 01.02, OA 01.03
11:30 - 11:45 | Presenter: Jin Hee Kim
- Abstract
No abstract available for this presentation
-
+
OA 01.05 - Analysis of Radiotherapy Quality Assurance Data for the Convert Trial - Does Non-Compliance to Protocol Affect Survival?
11:45 - 11:55 | Presenter: Elena Wilson | Author(s): N. Groom, Corinne Faivre-Finn
- Abstract
Loading... -
+
OA 01.06 - Radiation Therapy is Associated with an Increased Incidence of Cardiac Events in Small Cell Lung Cancer Patients
11:55 - 12:05 | Presenter: Matthew Jeffrey Ferris | Author(s): R. Jiang, K. Ward, Suresh S Ramalingam, M. Behera, Kristin A Higgins
- Abstract
Loading... -
+
OA 01.07 - Tracking Major Symptom Burden from Chemotherapy Concurrent with 3D vs. IMRT vs. Proton Beam Radiotherapy for NSCLC
12:05 - 12:15 | Presenter: Qiuling Shi | Author(s): X.S. Wang, Z. Liao, George R. Simon, C.S. Cleeland
- Abstract
Loading... -
+
OA 01.08 - Discussant - OA 01.05, OA 01.06, OA 01.07
12:15 - 12:30 | Presenter: Yukinori Matsuo
- Abstract
No abstract available for this presentation